Intervention: Bortezomib 1.3 mg/m2/dose D1, D4, D8, D11 q21d.IC: smoking history of < 100 cigarettes, KRAS G12D, previously treated NSCLC.1EP: ORR. This evidence concerns the gene KRAS and non-small cell lung carcinoma.